Pharmaceutical Executive highlights "Shadow AI," where employees utilize unapproved AI tools without IT oversight.
The Story
The article details its increasing impact on pharma companies, posing risks to data security and compliance.
Why It Matters
This isn't just IT's problem; it’s a board-level risk. Your people are already using AI tools for quick tasks, often with sensitive data, completely bypassing governance. With the EU AI Act enforcement in August 2026, uncontrolled AI usage means hefty fines and IP loss. You're likely paying for Copilot, but using it correctly? Doubtful.
What To Do About It
I can help you audit existing AI use, implement secure, governed Copilot workflows within Microsoft 365, and build an
Sources
Related Signals
Flagright, a new AI operating system for compliance, just secured $12.5M in funding.
17 Jun 2026
Pharma compliance is actively adapting to new AI tools and emerging regulation.
6 Jun 2026
Weverse Brain was selected for South Korea's Ministry of Science and ICT's "Advanced GPU Utilization Support Project".
2 Jun 2026